Abstract

Parkinson’s disease (PD) is a complex multisystem disorder with motor and non-motor symptoms (NMS). NMS may have an even greater impact on quality of life than motor symptoms. Subthalamic nucleus deep brain stimulation (STN-DBS) has been shown to improve motor fluctuations and quality of life, whereas the effects on different NMS have been less examined. Sleep disturbances and autonomic dysfunction are among the most prevalent NMS. We here report the efficacy of STN-DBS on sleep disturbances and autonomic dysfunction. In the parent trial, 60 patients were included in a single-center randomized prospective study, with MDS-UPDRS III and PDQ-39 as primary endpoints at 12 months of STN-DBS. Preplanned assessments at baseline and postoperatively at 3 and 12 months also included Parkinson’s Disease Sleep Scale (PDSS); Scopa-Aut; and MDS-UPDRS I, II, and IV. We found that STN-DBS had a significant and lasting positive effect on overall sleep quality, nocturnal motor symptoms and restlessness, and daytime dozing. Several aspects of autonomic dysfunction were also improved at 3 months postoperatively, although at 12 months only thermoregulation (sudomotor symptoms) remained significantly improved. We could not identify preoperative factors that predicted improvement in PDSS or Scopa-Aut. There was a close relationship between improved autonomic symptoms and improved quality of life after 1 year. NMS and especially sleep and autonomic dysfunction deserve more focus to improve patient outcomes further.

Highlights

  • Parkinson’s disease (PD) is a complex multisystem disorder with motor and non-motor symptoms (NMS)

  • When oral medical treatment proves to be insufficient in reducing tremor or motor fluctuations, deep brain stimulation (DBS) is an effective and well-established symptomatic treatment option[11,12,13]

  • We have evaluated the impact of bilateral Subthalamic nucleus deep brain stimulation (STN-DBS) on sleep problems and dysautonomia during the first year of chronic stimulation and explored their relationship to motor and quality-of-life outcomes

Read more

Summary

Introduction

Parkinson’s disease (PD) is a complex multisystem disorder with motor and non-motor symptoms (NMS). NMS may have an even greater impact on quality of life than motor symptoms. Subthalamic nucleus deep brain stimulation (STN-DBS) has been shown to improve motor fluctuations and quality of life, whereas the effects on different NMS have been less examined. We here report the efficacy of STN-DBS on sleep disturbances and autonomic dysfunction. NMS have a significant impact on quality of life[6], often even to a greater extent than motor symptoms[7,8,9,10]. When oral medical treatment proves to be insufficient in reducing tremor or motor fluctuations, deep brain stimulation (DBS) is an effective and well-established symptomatic treatment option[11,12,13]. The significance of NMS in the DBS-treated cohorts and the effect of DBS on these symptoms are reflected by several publications on this topic during the past years[14,15,16]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call